Table 1 Relationship between IKBIP expression and clinicopathological features of PRCC
From: Prognostic value of IKBIP in papillary renal cell carcinoma
Characteristic | levels | Low expression of IKBIP | High expression of IKBIP | p |
|---|---|---|---|---|
n | 144 | 145 | ||
Age, n (%) | < = 60 | 55 (19.2%) | 78 (27.3%) | 0.012 |
> 60 | 87 (30.4%) | 66 (23.1%) | ||
Gender, n (%) | Female | 33 (11.4%) | 44 (15.2%) | 0.195 |
Male | 111 (38.4%) | 101 (34.9%) | ||
Pathological stage, n (%) | Stage I | 97 (37.3%) | 75 (28.8%) | 0.013 |
Stage II | 10 (3.8%) | 12 (4.6%) | ||
Stage III | 20 (7.7%) | 31 (11.9%) | ||
Stage IV | 3 (1.2%) | 12 (4.6%) | ||
Pathological T stage, n (%) | T1 | 109 (38%) | 84 (29.3%) | 0.006 |
T2 | 12 (4.2%) | 21 (7.3%) | ||
T3 | 22 (7.7%) | 37 (12.9%) | ||
T4 | 0 (0%) | 2 (0.7%) | ||
Pathological N stage, n (%) | N0 | 28 (36.4%) | 21 (27.3%) | 0.005 |
N1 | 6 (7.8%) | 18 (23.4%) | ||
N2 | 0 (0%) | 4 (5.2%) | ||
Pathological M stage, n (%) | M0 | 49 (47.1%) | 46 (44.2%) | 0.161 |
M1 | 2 (1.9%) | 7 (6.7%) | ||
OS event, n (%) | Alive | 131 (45.3%) | 114 (39.4%) | 0.006 |
Dead | 13 (4.5%) | 31 (10.7%) |